только для медицинских специалистов
Консультант врача. Электронная медицинская библиотека

Консультант врача

Электронная медицинская библиотека

Доступ к библиотеке Версия для слабовидящих
Раздел 11 / 17
Страница 1 / 1

Список литературы

  1. Higgins RD et al. Bronchopulmonary dysplasia: Executive summary of a workshop. J Pediatr. 2018;197:300–8. doi: 10.1016/j.jpeds.2018.01.043
  2. Wang S-H, Tsao P-N. Phenotypes of Bronchopulmonary Dysplasia. Int J Mol Sci . 2020 Aug 25;21(17):6112. doi: 10.3390/ijms21176112.
  3. Thébaud B., Goss K.N., Laughon M. et al. Bronchopulmonary dysplasia. Nat Rev Dis Primers. 2020; 5(1): 78. doi:10.1038/s41572-019-0127-7.
  4. Bonadies L., Zaramella P., Porzionato A., et al. Present and Future of Bronchopulmonary Dysplasia. J. Clin. Med. 2020; 9, 1539; doi:10.3390/jcm9051539
  5. Kim S-H, Chun J., Ko K-H, et al. Effect of antenatal azithromycin for Ureaplasma spp. on neonatal outcome at ≤30 weeks' gestational age. Pediatr Int. 2019 Jan;61(1):58-62. doi: 10.1111/ped.13738.
  6. Dassios T, Williams EE, Hickey A, Greenough A. Duration of mechanical ventilation and prediction of bronchopulmonary dysplasia and home oxygen in extremely preterm infants. Acta Paediatr. 2021 Feb 8. doi: 10.1111/apa.15801.
  7. McEvoy C.T., Spindel E.R. Pulmonary Effects of Maternal Smoking on the Fetus and Child: Effects on Lung Development, Respiratory Morbidities, and Life Long Lung Health. Paediatr Respir Rev. 2017; 21: 27–33. doi: 10.1016/j.prrv.2016.08.005.
  8. Tanaka S, Tsumura K, Nakura Y, et al. New antibiotic regimen for preterm premature rupture of membrane reduces the incidence of bronchopulmonary dysplasia. J Obstet Gynaecol Res. 2019 May;45(5):967-973. doi: 10.1111/jog.13903.
  9. Овсянников Д.Ю., Кравчук Д.А., Николаева Д.Ю. Клиническая патофизиология органов дыхания недоношенных детей. Неонатология: новости, мнения, обучение. 2018; 6 (3): 74-98.
  10. Thekkeveedu R.K., Guaman M.K., Shivanna B. Bronchopulmonary dysplasia: A Review of Pathogenesis and Pathophysiology. Respir Med . 2017 November ; 132: 170–177. doi:10.1016/j.rmed.2017.10.014.
  11. Berkelhamer SK, Mestan KK, Steinhorn R. An update on the diagnosis and management of bronchopulmonary dysplasia (BPD)-associated pulmonary hypertension. Semin Perinatol. 2018 Nov;42(7):432-443. doi: 10.1053/j.semperi.2018.09.005.
  12. Chaw PS, Hua L, Cunningham S, Campbell H, Mikolajczyk R, Nair H; RESCEU Investigators. Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infections in Children With Bronchopulmonary Dysplasia: Systematic Review and Meta- Analysis. J Infect Dis . 2020 Oct 7;222(Suppl 7):S620-S627. doi: 10.1093/infdis/jiz492.
  13. Lal CV, Ambalavanan N. Genetic predisposition to bronchopulmonary dysplasia. Semin Perinatol. 2015 Dec;39(8):584-91. doi: 10.1053/j.semperi.2015.09.004.
  14. Hamvas A, Feng R, Bi Y, Wang F, Bhattacharya S, et al. Exome sequencing identifies gene variants and networks associated with extreme respiratory outcomes following preterm birth. BMC Genet. 2018 Oct 20;19(1):94. doi: 10.1186/s12863-018-0679-7.
  15. Gao J, Wu M, Wang F, Jiang L, Tian R, Zhu X, He S. CD74, a novel predictor for bronchopulmonary dysplasia in preterm infants. Medicine (Baltimore). 2020 Nov 25;99(48):e23477. doi: 10.1097/MD.0000000000023477.
  16. Leong M. Genetic Approaches to Bronchopulmonary Dysplasia. Neoreviews. 2019 May;20(5):e272-e279. doi: 10.1542/neo.20-5-e272.
  17. Trittmann JK, Velten M, Heyob KM, Almazroue H, Jin Y, Nelin LD, Rogers LK. Arginase and α-smooth muscle actin induction after hyperoxic exposure in a mouse model of bronchopulmonary dysplasia. Clin Exp Pharmacol Physiol. 2018 Jun;45(6):556- 562. doi: 10.1111/1440-1681.12909.
  18. Abed NT, Abdelhaie OM, Almonaem ERA, Mansour AI. Relation of asymmetric dimethylarginine with pulmonary morbidities in neonatal respiratory distress syndrome. J Neonatal Perinatal Med. 2021 Feb 23. doi: 10.3233/NPM-200604.
  19. Бронхолегочная дисплазия. Монография. Под редакцией Д.Ю. Овсянникова, Н.А. Геппе, А.Б. Малахова, Д.Н. Дегтярева. М.: 2020
  20. Higgins R.D., Jobe A.H., Koso-Thomas M., et al. Bronchopulmonary Dysplasia: Executive Summary of a Workshop. J Pediatr. 2018 June; 197: 300–308. doi:10.1016/j.jpeds.2018.01.043.
  21. Jobe A. H., Bancalari E. Bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 2001; 163: 1723-1729.
  22. Овсянников Д. Ю. Система оказания медицинской помощи детям, страдающим бронхолегочной дисплазией: Руководство для практикующих врачей / под ред. Л. Г. Кузьменко. М.: МДВ, 2010. С. 152.
  23. Баранов А.А., Намазова-Баранова Л.С., Володин Н.Н., и др. Ведение детей с бронхолегочной дисплазией. Педиатрическая фармакология. 2016;13(4):319-333. https://doi.org/10.15690/pf.v13i4.1603
  24. Sweet DG, Carnielli V, Greisen G, et al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update. Neonatology. 2019;115(4):432-450. doi: 10.1159/000499361.
  25. Voynow JA. "New" bronchopulmonary dysplasia and chronic lung disease. Paediatr Respir Rev. 2017 Sep;24:17-18. doi: 10.1016/j.prrv.2017.06.006.
  26. Shalish W, Kanbar L, Kovacs L, et al. The Impact of Time Interval between Extubation and Reintubation on Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants. J Pediatr. 2019 Feb;205:70-76.e2. doi: 10.1016/j.jpeds.2018.09.062.
  27. Soliman N, Chaput K, Alshaikh B, Yusuf K. Preeclampsia and the Risk of Bronchopulmonary Dysplasia in Preterm Infants Less Than 32 Weeks' Gestation. Am J Perinatol. 2017 May;34(6):585-592. doi: 10.1055/s-0036-1594017.
  28. Morrow LA, Wagner BD, Ingram DA, et al. Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm Infants. Am J Respir Crit Care Med. 2017 Aug 1;196(3):364-374. doi: 10.1164/rccm.201612-2414OC.
  29. Mirza H, Garcia J, McKinley G, Hubbard L, et al. Duration of significant patent ductus arteriosus and bronchopulmonary dysplasia in extremely preterm infants. J Perinatol 2019 Dec;39(12):1648-1655.doi: 10.1038/s41372-019-0496-5.
  30. Jung E., Lee B.S. Late-Onset Sepsis as a Risk Factor for Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants: A Nationwide Cohort Study Sci Rep. 2019; 9(1): 15448.
  31. Kim SH, Han YS, Chun J, Lee MH, Sung TJ. Risk factors that affect the degree of bronchopulmonary dysplasia: Comparison by severity in the same gestational age. PLoS One. 2020 Jul 16;15(7):e0235901.doi: 10.1371/journal.pone.0235901.
  32. Patel RM, Knezevic A, Yang J, et al. Enteral iron supplementation, red blood cell transfusion, and risk of bronchopulmonary dysplasia in very-low-birth-weight infants. Transfusion. 2019 May;59(5):1675-1682. doi: 10.1111/trf.15216.
  33. Yen JM, Lin CH, Yang MM, Hou ST, et al. Eosinophilia in very low birth weight infants. Pediatr Neonatol. 2010 Apr;51(2):116-23. doi: 10.1016/S1875-9572(10)60021-6.
  34. Kurata H, Ochiai M, Inoue H, et al. Inflammation in the neonatal period and intrauterine growth restriction aggravate bronchopulmonary dysplasia. Pediatr Neonatol. 2019 Oct;60(5):496-503. doi: 10.1016/j.pedneo.2018.11.007
  35. Askenazi D, Patil NR, Ambalavanan N, et al. Acute kidney injury is associated with bronchopulmonary dysplasia/mortality in premature infants. Pediatr Nephrol. 2015 Sep;30(9):1511-8.doi: 10.1007/s00467-015-3087-5.
  36. Starr MC, Boohaker L, Eldredge LC, Menon S, et al. Acute Kidney Injury and Bronchopulmonary Dysplasia in Premature Neonates Born Less than 32 Weeks' Gestation. Am J Perinatol. 2020 Feb;37(3):341-348. doi: 10.1055/s-0039-3400311.
  37. Klevebro S, Westin V, Stoltz Sjöström E, et al. Early energy and protein intakes and associations with growth, BPD, and ROP in extremely preterm infants. Clin Nutr. 2019 Jun;38(3):1289-1295. doi: 10.1016/j.clnu.2018.05.012.
  38. Chen C, Weng H, Zhang X, et al. Low-Dose Vitamin D Protects Hyperoxia-Induced Bronchopulmonary Dysplasia by Inhibiting Neutrophil Extracellular Traps. Front Pediatr. 2020 Jul 3;8:335.doi: 10.3389/fped.2020.00335.
  39. https://www.medscape.com/pediatrics
  40. Greenough A., Kavvadia K., Johnson A. H. et al. A new simple chest radiograph score to predict chronic lung disease in prematurely born infants. British J. Radiol. 1999; 72: 530- 533.
  41. Duijts L, van Meel ER, Moschino L, et al. European Respiratory Society guideline on long-term management of children with bronchopulmonary dysplasia. Eur Respir J 2020; 55: 1900788 [https://doi.org/10.1183/13993003.00788-2019].
  42. Hayes D. Jr., Wilson K.C., Krivchenia K., et al. Home Oxygen Therapy for Children An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2019; 199(3): e5–e23. doi: 10.1164/rccm.201812-2276ST.
  43. Функциональная диагностика и клиническая респираторная патофизиология бронхолегочной дисплазии: от младенцев до взрослых / Под ред. Е.Г. Фурмана, Д.Ю. Овсянникова. – Москва – Пермь: Изд-во Перм. нац. исслед. политехн. ун-та, 2020. – 167 с.
  44. Kulkarni G, de Waal K, Grahame S, Collison A, et al. Polysomnography for the management of oxygen supplementation therapy in infants with chronic lung disease of prematurity. J Matern Fetal Neonatal Med. 2019 Nov;32(21):3640-3646. doi: 10.1080/14767058.2018.1470234.
  45. De Pieri C, Amaddeo A, Fauroux B. About the role of polysomnography in weaning and titration of home oxygen therapy in children with bronchopulmonary dysplasia. J Matern Fetal Neonatal Med. 2020 Mar;33(5):875. doi: 10.1080/14767058.2018.1500548.
  46. Joosten K., de Goederen R., Pijpers A., et al. Sleep related breathing disorders and indications for polysomnography in preterm infants. Early.Hum.Dev. 2017;113:114-119 doi: 10.1016/j.earlhumdev.2017.07.005.
  47. Behnke J, Lemyre B, Czernik C, Zimmer KP, Ehrhardt H, Waitz M: Non-invasive ventilation in neonatology. Dtsch Arztebl Int 2019; 116: 177–83. DOI: 10.3238/arztebl.2019.0177
  48. Gibbs K, Jensen EA, Alexiou S, Munson D, Zhang H. Ventilation Strategies in Severe Bronchopulmonary Dysplasia. Neoreviews. 2020 Apr;21(4):e226-e237. doi: 10.1542/neo.21-4-e226.
  49. Rhein L, White H, Simoneau T, et al. Transmitted Home Oximetry and Duration of Home Oxygen in Premature Infants. Pediatrics. 2020 Aug;146(2):e20200079. doi: 10.1542/peds.2020-0079.
  50. Тяжелая бронхолегочная дисплазия: Медицинское сопровождение на дому / Савва Н. Н., Овсянников Д. Ю., Жесткова М. А. и др.; под ред. Д. Ю. Овсянникова, Н. Н. Саввы. — М.: Издательство «Проспект», 2020. — 120 с.: ил.
  51. Filippone M., Nardo D., Bonadies L., et al. Update on Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia. Am J Perinatol. 2019;36(S 02):S58-S62. doi: 10.1055/s-0039-1691802.
  52. Shinwell E.S., Portnov I., Meerpohl J.J., et al. Inhaled Corticosteroids for Bronchopulmonary Dysplasia: A Meta-analysis. Pediatrics. 2016; 138(6). pii: e20162511. doi: 10.1542/peds.2016-2511.
  53. Muehlbacher, T.; Bassler, D.; Bryant, M.B. Evidence for the Management of Bronchopulmonary Dysplasia in Very Preterm Infants. Children 2021;8:298. https://doi.org/10.3390/children8040298
  54. Charkaluk ML, Rousseau J, Dehouck-Vallois M, et al. Occurrence and severity of acute respiratory infections during the first year among very preterm infants: an Epipage-2 cohort analysis. Eur J Pediatr. 2021 Jun;180(6):1833-1840. doi: 10.1007/s00431-021- 03956-w.
  55. Narayan O, Bentley A, Mowbray K, et al. Updated cost-effectiveness analysis of palivizumab (Synagis) for the prophylaxis of respiratory syncytial virus in infant populations in the UK. J Med Econ. 2020 Dec;23(12):1640-1652. doi: 10.1080/13696998.2020.1836923.
  56. Баранов А.А., Намазова-Баранова Л.С., Беляева И.А. и др. Иммунопрофилактика инфекционных болезней у недоношенных детей // Педиатрическая фармакология. 2018. № 15 (5). С. 376–389.
  57. Charles E, Hunt KA, Harris C, Hickey A, Greenough A. Small for gestational age and extremely low birth weight infant outcomes. J Perinat Med. 2019 Feb 25;47(2):247-251. doi: 10.1515/jpm-2018-0295.
  58. Davidson LM, Berkelhamer SK. Bronchopulmonary Dysplasia: Chronic Lung Disease of Infancy and Long-Term Pulmonary Outcomes. J Clin Med. 2017 Jan 6;6(1):4. doi: 10.3390/jcm6010004.

Для продолжения работы требуется вход / регистрация